Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2017-03-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.7b00141PMID 28319392PMCID PMC5501184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation

  2018cited by this paper
• Adenosine: Synthetic Methods of Its Derivatives and Antitumor Activity

  2018cited by this paper
• Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

  2018cited by this paper
• Identification of A3 adenosine receptor agonists as novel non‐narcotic analgesics

  2016cited by this paper
• The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis

  2016cited by this paper
• Stimulants for depression: On the up and up?

  2016cited by this paper
• Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists.

  2016cited by this paper
• Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors

  2016cited by this paper
• X-ray structures and mechanism of the human serotonin transporter

  2016cited by this paper
• Allosteric Mechanisms of Molecular Machines at the Membrane: Transport by Sodium-Coupled Symporters.

  2016influential reference
• Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine

  2016cited by this paper
• Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?

  2016cited by this paper
• Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain

  2015cited by this paper
• Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy.

  2015cited by this paper
• Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder.

  2015cited by this paper
• Designing modulators of monoamine transporters using virtual screening techniques

  2015cited by this paper
• Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.

  2015cited by this paper
• Metabolic mapping of A3 adenosine receptor agonist MRS5980.

  2015cited by this paper
• Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant

  2015cited by this paper
• Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.

  2015cited by this paper
• Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.

  2015cited by this paper
• Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

  2015cited by this paper
• Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats

  2015cited by this paper
• Renal Effects of Added Low-dose Dopamine in Acute Heart Failure Patients With Diuretic Resistance to Natriuretic Peptide

  2015cited by this paper
• Neurotransmitter and psychostimulant recognition by the dopamine transporter

  2015cited by this paper
• In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A3 Adenosine Receptor Agonists

  2014cited by this paper
• Structural Probing of Off-Target G Protein-Coupled Receptor Activities within a Series of Adenosine/Adenine Congeners

  2014cited by this paper
• Structural basis for action by diverse antidepressants on biogenic amine transporters

  2013cited by this paper
• Mechanisms of dopamine transporter regulation in normal and disease states.

  2013cited by this paper
• Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.

  2012cited by this paper
• Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.

  2012cited by this paper
• Prime‐, Stress‐, and Cue‐Induced Reinstatement of Extinguished Drug‐Reinforced Responding in Rats: Cocaine as the Prototypical Drug of Abuse

  2012cited by this paper
• Automated design of ligands to polypharmacological profiles

  2012cited by this paper
• Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation

  2012cited by this paper
• Privileged scaffolds for library design and drug discovery.

  2010cited by this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cited by this paper
• Comparison of dopamine and norepinephrine in the treatment of shock.

  2010cited by this paper
• Comparison of Dopamine and Norepinephrine in the treatment of shock.

  2010cited by this paper
• Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.

  2008cited by this paper
• The binding sites for cocaine and dopamine in the dopamine transporter overlap

  2008cited by this paper
• Synthesis of Ethyl (1S,2R,3S,4S,5S)-2,3-O-(Isopropylidene)-4-Hydroxy-Bicyclo[3.1.0]Hexane-Carboxylate from L-Ribose: A Versatile Chiral Synthon for Preparation of Adenosine and P2 Receptor Ligands

  2008cited by this paper
• χ-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model*

  2007cited by this paper
• Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse

  2006cited by this paper
• Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents.

  2005cited by this paper
• Regulation of lung edema clearance by dopamine.

  2003cited by this paper
• Probes for the dopamine transporter: New leads toward a cocaine‐abuse therapeutic—A focus on analogues of benztropine and rimcazole

  2002cited by this paper
• Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.

  2000cited by this paper
• Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue.

  1999cited by this paper
• Molecular cloning and functional expression of the mouse dopamine transporter

  1999cited by this paper
• Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

  1999cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988cited by this paper
• Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.

  1985cited by this paper
• Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling.

  2025cites this paper
• (N)-Methanocarba-adenosines as monoamine transporter allosteric inhibitors: Extended N6 groups for bitopic stabilization.

  2025cites this paper
• Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development

  2025cites this paper
• Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling

  2024cites this paper
• Structure of the human dopamine transporter and mechanisms of inhibition

  2024cites this paper
• Research Progress in Nucleoside Antiviral Drugs

  2023cites this paper
• Dual N6/C7-Substituted 7-Deazapurine and Tricyclic Ribonucleosides with Affinity for G Protein-Coupled Receptors.

  2023cites this paper
• Structure activity relationships of 5-HT2B and 5-HT2C serotonin receptor antagonists: N6, C2 and 5'-Modified (N)-methanocarba-adenosine derivatives.

  2023cites this paper
• Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.

  2021cites this paper
• Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2

  2021cites this paper
• Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists.

  2020cites this paper
• Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1)

  2019cites this paper
• Insights into the mechanism and pharmacology of neurotransmitter sodium symporters.

  2019cites this paper
• Medicinal Chemistry of the A 3 Adenosine Receptor

  2018cites this paper
• Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

  2018cites this paper
• Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters.

  2018cites this paper
• Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation

  2018cites this paper
• A binding kinetics study of human adenosine A3 receptor agonists

  2018cites this paper
• Adenosine: Synthetic Methods of Its Derivatives and Antitumor Activity

  2018influential citation
• Tungstate catalysis: pressure-switched 2- and 6-electron reductive functionalization of CO2 with amines and phenylsilane

  2018cites this paper
• Polypharmacology of conformationally locked methanocarba nucleosides.

  2017cites this paper